UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | R | S | T | W
Number of items: 108.

A

Abusedra, A; Vulliamy, T; Gilmore, JD; Bybee, A; Hawkins, PN; Laffan, M; Apperley, JF; (1999) Immunoglobulin gene rearrangement in AL amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 124-126). PARTHENON PUBLISHING GROUP LTD

Aganna, E; McDermott, MF; Booth, D; Ogunkolade, BW; Hitman, GA; Hawkins, PN; (1999) Genetic heterogeneity in autosomal dominant recurrent fevers. In: (pp. A280-A280). UNIV CHICAGO PRESS

Ames, PRJ; Alves, J; Inanc, M; Isenberg, DA; Nourooz-Zadeh, J; (1999) Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. RHEUMATOLOGY , 38 (6) 529 - 534.

B

Bellotti, V; Mangione, P; Stoppini, M; (1999) Biological activity and pathological implications of misfolded proteins. Cellular and Molecular Life Sciences , 55 (7) p. 977. 10.1007/s000180050348.

Bickerstaff, MCM; Botto, M; Hutchinson, WL; Herbert, J; Tennent, GA; Bybee, A; Mitchell, DA; ... Pepys, MB; + view all (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. NAT MED , 5 (6) 694 - 697.

Booth, DR; Booth, SE; Gillmore, JD; Hawkins, PN; Pepys, MB; (1999) Alpha-1 antiprotease alleles as risk factors in AA amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 414 - 416). PARTHENON PUBLISHING GROUP LTD

Booth, DR; Booth, SE; Gillmore, JD; Hawkins, PN; Pepys, MB; (1999) SAA(1) alleles as risk factors in AA amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 369 - 371). PARTHENON PUBLISHING GROUP LTD

Booth, DR; Gillmore, JD; Pepys, MB; Hawkins, PN; (1999) Transthyretin mutations in amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 554 - 555). PARTHENON PUBLISHING GROUP LTD

Brancaccio, D; Bellotti, V; Losi, B; Padovese, P; Cozzolino, M; Carpani, P; Mangione, P; ... Gallieni, M; + view all (1999) Effects of a Vitamin E-Modified Dialyzer (Excebrane®) on β2-microglobulin structure and removal. Contrib Nephrol , 127 pp. 147-155.

Brancaccio, D; Bellotti, V; Losi, B; Padovese, P; Cozzolino, M; Carpani, P; Mangione, P; ... Gallieni, M; + view all (1999) Effects of a vitamin E-modified dialyzer (Excebrane) on β2-microglobulin structure and removal. Contributions to Nephrology , 127 pp. 147-155.

Brett, M; Persey, MR; Reilly, MM; Revesz, T; Booth, DR; Booth, SE; Hawkins, PN; ... Morgan-Hughes, JA; + view all (1999) Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. BRAIN , 122 183 - 190.

C

Carvalho, D; Savage, COS; Isenberg, D; Pearson, JD; (1999) IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. ARTHRITIS AND RHEUMATISM , 42 (4) pp. 631-640. 10.1002/1529-0131(199904)42:4<631::AID-ANR5>3.0.CO;2-X.

Choy, EHS; Rankin, ECC; Kassimos, D; Vetterlein, O; Garyfallos, A; Ravirajan, CT; Sopwith, M; ... Panayi, GS; + view all (1999) The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis. J RHEUMATOL , 26 (11) 2310 - 2317.

Clarke, AE; Petri, MA; Manzi, S; Isenberg, DA; Gordon, C; Senecal, JL; St Pierre, Y; ... Esdaile, JM; + view all (1999) An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol , 26 (7) pp. 1500-1511.

Cockerill, GW; Saklatvala, J; Ridley, SH; Yarwood, H; Miller, NE; Oral, B; Nithyanathan, S; ... Haskard, DO; + view all (1999) High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler Thromb Vasc Biol , 19 (4) pp. 910-917.

Crawley, E; Isenberg, D; Woo, P; Kay, R; (1999) Interleukin-10 promoter polymorphism and lupus nephritis: comment on the article by Mok et al [letter; comment]. Arthritis and Rheumatism , 42 (3) pp. 590-593.

Crawley, E; Isenberg, D; Woo, P; Kay, R; Chi Chiu Mok, ; Chak Sing Lau, ; Lanchbury, JS; (1999) Interleukin-10 promoter polymorphism and lupus nephritis: Comment on the article by Mok et al [6] (multiple letters). Arthritis and Rheumatism , 42 (3) pp. 590-593.

Crawley, E; Woo, P; Isenberg, DA; (1999) Single nucleotide polymorphic haplotypes of the interleukin-10 5 ' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. ARTHRITIS RHEUM , 42 (9) 2017 - 2018.

D

Danesh, J; Muir, J; Wong, YK; Ward, M; Gallimore, JR; Pepys, MB; (1999) Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J , 20 (13) pp. 954-959. 10.1053/euhj.1998.1309.

Denton, CP; Bunce, TD; Dorado, MB; Roberts, Z; Wilson, H; Howell, K; Bruckdorfer, KR; (1999) Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology (Oxford) , 38 (4) pp. 309-315. 10.1093/rheumatology/38.4.309.

Dziadzio, M; Denton, CP; Smith, R; Howell, K; Blann, A; Bowers, E; Black, CM; (1999) Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum , 42 (12) pp. 2646-2655. 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T.

E

Edwards, JCW; Cambridge, G; Abrahams, VM; (1999) Do self-perpetuating B lymphocytes drive human autoimmune disease? IMMUNOLOGY , 97 (2) pp. 188-196.

Ehrenstein, MR; (1999) Antinuclear antibodies and lupus: causes and consequences. RHEUMATOLOGY , 38 (8) 691 - 693.

Ehrenstein, MR; (1999) Antinuclear antibodies and lupus: causes and consequences [editorial]. Rheumatology , 38 (8) pp. 691-693.

Ehrenstein, MR; Neuberger, MS; (1999) Deficiency in MSH2 affects the efficiency and local sequence specificity of immunoglobulin class switch recombination and somatic hypermutation. ARTHRITIS RHEUM , 42 (9) S52 - S52.

Ehrenstein, MR; Neuberger, MS; (1999) Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J , 18 (12) 3484 - 3490.

Erskine, PT; Newbold, R; Roper, J; Coker, A; Warren, MJ; Shoolingin-Jordan, PM; Wood, SP; (1999) The Schiff base complex of yeast 5-aminolaevulinic acid dehydratase with laevulinic acid. PROTEIN SCI , 8 (6) 1250 - 1256.

Erskine, PT; Norton, E; Cooper, JB; Lambert, R; Coker, A; Lewis, G; Spencer, P; ... Schoolingin-Jordan, PM; + view all (1999) X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 angstrom resolution. BIOCHEMISTRY-US , 38 (14) 4266 - 4276.

F

Fonseca, C; Abraham, D; Black, CM; (1999) Lung fibrosis. SPRINGER SEMINARS IN IMMUNOPATHOLOGY , 21 (4) pp. 453-474. 10.1007/BF00870305.

Frank, MB; McCubbin, V; Trieu, E; Wu, YJ; Isenberg, DA; Targoff, IN; (1999) The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J AUTOIMMUN , 12 (2) 137 - 142.

Frohlich, M; Doring, A; Imhof, A; Hutchinson, WL; Pepys, MB; Koenig, W; (1999) Oral contraceptive use is associated with a systemic acute phase response. FIBRINOLYSIS PROTEOL , 13 (6) 239 - 244.

G

Gao, B; Cash, D; Abraham, D; Black, C; Bruckdorfer, KR; Jacobs, M; (1999) Sera from patients with primary Raynaud's disease and limited scleroderma alter vascular responsiveness in the rabbit aorta. In: (pp. 153-).

Gill, R; (1999) The solution structure of IGF-1 and receptor binding. Growth Hormone and IGF Research , 9 (5) p. 322.

Gill, R; Verma, C; Wallach, B; Ursø, B; Pitts, J; Wollmer, A; De Meyts, P; (1999) Modelling of the disulphide-swapped isomer of human insulin-like growth factor-1: implications for receptor binding. Protein Eng , 12 (4) pp. 297-303.

Gillmore, JD; Apperley, JF; Craddock, C; Madhoo, S; Pepys, MB; Hawkins, PN; (1999) High-dose melphalan and stem cell rescue for AL amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 102 - 104). PARTHENON PUBLISHING GROUP LTD

Gillmore, JD; Apperley, JF; Pepys, MB; Hawkins, PN; (1999) High dose chemotherapy for systemic AL amyloidosis. KIDNEY INT , 55 (5) 2103 - 2103.

Gillmore, JD; Booth, DR; Madhoo, S; Pepys, MB; Hawkins, PN; (1999) Hereditary renal amyloidosis associated with variant lysozyme in a large English family. NEPHROL DIAL TRANSPL , 14 (11) 2639 - 2644.

Gillmore, JD; Booth, DR; Pepys, MB; Hawkins, PN; (1999) Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart , 82 (3) , Article e2. 10.1136/hrt.82.3.e2.

Gillmore, JD; Booth, DR; Rela, M; Heaton, ND; Williams, RS; Harrison, P; Pepys, MB; (1999) Curative hepatorenal transplantation for systemic amyloidosis associated with fibrinogen alpha-chain Glu526Val in an English family. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 336 - 338). PARTHENON PUBLISHING GROUP LTD

Gillmore, JD; Hawkins, PN; (1999) Amyloidosis and the respiratory tract. THORAX , 54 (5) 444 - 451.

Gillmore, JD; Lovat, LB; Hawkins, PN; (1999) Amyloidosis and the liver. J Hepatol , 30 Sup pp. 17-33.

Gillmore, JD; Lovat, LB; Persey, MR; Madhoo, S; Gallimore, JR; Pepys, MB; Hawkins, PN; (1999) Cumulative SAA production and outcome of AA amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 402 - 404). PARTHENON PUBLISHING GROUP LTD

Gillmore, JD; Persey, MR; Lovat, LB; Madhoo, S; Pepys, MB; Hawkins, PN; (1999) Serum amyloid P component scintigraphy in AL amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 148 - 150). PARTHENON PUBLISHING GROUP LTD

Gorecki, DC; Simons, JP; (1999) The dangers of DNA vaccination. NAT MED , 5 (2) 126 - 126.

Gorecki, DC; Szklarczyk, A; Lukasiuk, K; Kaczmarek, L; Simons, JP; (1999) Differential seizure-induced and developmental changes of neurexin expression. MOL CELL NEUROSCI , 13 (3) 218 - 227.

Griselli, M; Herbert, J; Hutchinson, WL; Taylor, KM; Sohail, M; Krausz, T; Pepys, MB; (1999) C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J EXP MED , 190 (12) 1733 - 1739.

H

Hawkins, PN; Aprile, C; Capri, G; Vigano, L; Munzone, E; Gianni, L; Pepys, MB; (1999) Scintigraphic imaging and turnover studies with (131) I-serum amyloid P component (SAP) in systemic amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 139-141). PARTHENON PUBLISHING GROUP LTD

Hawkins, PN; Herbert, J; McBride, A; Hutchinson, WL; Pepys, MB; (1999) Natural history of experimental murine AA amyloidosis. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 387-389). PARTHENON PUBLISHING GROUP LTD

Hawkins, PN; Rydh, A; Danielsson, A; Cajander, S; Hietala, SO; Ahlstrom, KR; Pepys, MB; (1999) SAP scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 333-335). PARTHENON PUBLISHING GROUP LTD

Holland, JW; Taylor, GW; Rowley, AF; (1999) The eicosanoid generating capacity of isolated cell populations from the gills of the rainbow trout, Oncorhynchus mykiss. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol , 122 (3) pp. 297-306.

Hussain, S; Isenberg, DA; (1999) Autoimmune rheumatic diseases and the heart. HOSP MED , 60 (2) 95 - 99.

I

Ioannou, Y; Isenberg, DA; (1999) Immunisation of patients with systemic lupus erythematosus: the current state of play. LUPUS , 8 (7) 497 - 501.

Ioannou, Y; Sultan, S; Isenberg, DA; (1999) Myositis overlap syndromes. Curr Opin Rheumatol , 11 (6) pp. 468-474.

Isenberg, D; Ramsey Goldman, R; (1999) Assessing patients with lupus: towards a drug responder index. Rheumatology , 38 (11) pp. 1045-1049.

Isenberg, DA; Liang, MH; (1999) CNS lupus--where do we go from here? [editorial; comment]. Lupus , 8 (1) pp. 1-2.

K

Kalsi, J; Ravirajan, CT; Rahman, A; Isenberg, DA; (1999) Structure-function analysis and the molecular origins of anti-DNA antibodies in systemic lupus erythematosus. Expert Rev Mol Med , 1999 pp. 1-28. 10.1017/S1462399499000423.

Kerr, JR; Taylor, GW; Rutman, A; Hoiby, N; Cole, PJ; Wilson, R; (1999) Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. JOURNAL OF CLINICAL PATHOLOGY , 52 (5) pp. 385-387. 10.1136/jcp.52.5.385.

Knight, J; Taylor, GW; Wright, P; Clare, AS; Rowley, AF; (1999) Eicosanoid biosynthesis in an advanced deuterostomate invertebrate, the sea squirt (Ciona intestinalis). BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS , 1436 (3) pp. 467-478. 10.1016/S0005-2760(98)00153-2.

Koenig, W; Rothenbacher, D; Hoffmeister, A; Miller, M; Bode, G; Adler, G; Hombach, V; ... Brenner, H; + view all (1999) Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation , 100 (23) pp. 2326-2331. 10.1161/01.cir.100.23.2326.

Koenig, W; Sund, M; Fröhlich, M; Fischer, HG; Löwel, H; Döring, A; Hutchinson, WL; (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation , 99 (2) pp. 237-242. 10.1161/01.cir.99.2.237.

Kumar, S; Kalsi, JK; Ravirajan, CT; Rahman, A; Athwal, D; Latchman, D; Isenberg, DA; (1999) Molecular cloning. Expression and functional evaluation of the recombinant Fabs of human anti-DNA (B3) and anti-cardiolipin (UK4) antibodies and their hybrids. ARTHRITIS RHEUM , 42 (9) S308 - S308.

L

Lachmann, HJ; Griffiths, MH; Hoffbrand, BI; (1999) Kidney Disorders. In: Geraint James, D and Zumla, A, (eds.) The Granulomatous Disorders. (pp. 528-539). Cambridge University Press: Cambridge.

Liuzzo, G; Biasucci, LM; Gallimore, JR; Caligiuri, G; Buffon, A; Rebuzzi, AG; Pepys, MB; (1999) Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol , 34 (6) pp. 1696-1703. 10.1016/s0735-1097(99)00432-5.

Locke, IC; Leaker, B; Cambridge, G; (1999) A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions. CLIN EXP IMMUNOL , 115 (2) 369 - 376.

Loesch, A; Burnstock, G; (1999) From neuronal to endothelial vasopressin. In: (pp. p. 1).

Loesch, A; Burnstock, G; (1999) Localisation of immunoreactivity to ATP-gated P2X2 receptor in cerebrovascular endothelium. In: (pp. p. 2).

Loesch, A; Miah, S; Burnstock, G; (1999) Ultrastructural localisation of ATP-gated P2X<sub>2</sub> receptor immunoreactivity in the rat hypothalamo-neuropophysial system. Journal of Neurocytology , 28 (6) pp. 485-494.

Lovat, LB; Hohenester, E; Westermark, P; Wood, SP; Pepys, MB; (1999) Nature and specificity of amyloid fibril binding by serum amyloid P component. In: Kyle, RA and Gertz, MA, (eds.) AMYLOID AND AMYLOIDOSIS 1998. (pp. 29 - 31). PARTHENON PUBLISHING GROUP LTD

M

Mason, LJ; Timothy, LM; Isenberg, DA; Kalsi, JK; (1999) Immunization with a peptide of Sm B/B ' results in limited epitope spreading but not autoimmune disease. J IMMUNOL , 162 (9) 5099 - 5105.

Menon, S; Jameson-Shortall, E; Newman, SP; Hall-Craggs, MR; Chinn, R; Isenberg, DA; (1999) A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. ARTHRITIS AND RHEUMATISM , 42 (4) pp. 735-741. 10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L.

Mumford, AD; O'Donnell, J; Gillmore, JD; Manning, RA; Hawkins, PN; Laffan, M; (1999) Bleeding symptoms and coagulation test abnormalities in 308 patients with AL amyloidosis. BRIT J HAEMATOL , 105 27 - 27.

Mumford, AD; O'Donnell, J; Gillmore, JD; Manning, RA; Hawkins, PN; Laffan, M; (1999) Bleeding symptoms and coagulation test abnormalities in 337 patients with AL amyloidosis. THROMB HAEMOSTASIS 736 - 736.

N

Naoumova, RP; O'Neill, FH; Dunn, S; Neuwirth, CK; Taylor, GW; Axelson, M; Thompson, GR; (1999) Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway. Eur J Clin Invest , 29 (5) pp. 404-412. 10.1046/j.1365-2362.1999.00475.x.

Neuberger, MS; Lanoue, A; Ehrenstein, MR; Batista, FD; Sale, JE; Williams, GT; (1999) Antibody diversification and selection in the mature B-cell compartment. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY , 64 211 - 216.

Norsworthy, P; Theodoridis, E; Botto, M; Athanassiou, P; Beynon, H; Gordon, C; Isenberg, D; ... Davies, KA; + view all (1999) Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis and Rheumatism , 42 (9) pp. 1828-1832.

O

Obici, L; Bellotti, V; Mangione, P; Stoppini, M; Arbustini, E; Verga, L; Zorzoli, I; ... Merlini, G; + view all (1999) The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol , 155 (3) pp. 695-702. 10.1016/S0002-9440(10)65167-X.

P

Pepys, MB; (1999) Serum amyloid P component (not serum amyloid protein). Nat Med , 5 (8) pp. 852-853. 10.1038/11272.

Pourmand, N; Wahren-Herlenius, M; Gunnarsson, I; Svenungsson, E; Lofstrom, B; Ioannou, Y; Isenberg, DA; (1999) Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjogren's syndrome and systemic lupus erythematosus. ANN RHEUM DIS , 58 (10) 623 - 629.

R

Radway-Bright, EL; Inanc, M; Isenberg, DA; (1999) Animal models of the antiphospholipid syndrome. RHEUMATOLOGY , 38 (7) 591 - 601.

Rahman, A; Isenberg, DA; (1999) Autoantibodies in lupus nephritis. In: Lewis, EJ, (ed.) Lupus Nephritis. Oxford University Press: Oxford.

Rahman, A; Latchman, D; Isenberg, D; (1999) Sequence features of monoclonal antiphospholipid antibodies: comment on the article by Ikematsu et al. ARTHRITIS RHEUM , 42 (8) 1783 - 1784.

Rahman, A; Latchman, DS; Isenberg, DA; (1999) Sequence features of monoclonal anti-phospholipid antibodies. Arthritis and Rheumatism , 42 pp. 1783-1784.

Rahman, A; Stevenson, FK; Isenberg, DA; (1999) B cells: formation and structure of autoantibodies. In: Gaston, JSH, (ed.) Rheumatic disease - immunological mechanisms and prospects for new therapies. (pp. 61-78). Cambridge University Press: Cambridge.

Rajkumar, VS; Sundberg, C; Abraham, DJ; Rubin, K; Black, CM; (1999) Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. ARTHRITIS AND RHEUMATISM , 42 (5) pp. 930-941. 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.

Ramafi, G; Anderson, R; Theron, A; Feldman, C; Taylor, GW; Wilson, R; Cole, PJ; (1999) Exposure of N-formyl-L-methionyl-L-leucyl-L-phenylalanine-activated human neutrophils to the Pseudomonas aeruginosa-derived pigment 1-hydroxyphenazine is associated with impaired calcium efflux and potentiation of primary granule enzyme release. Infect Immun , 67 (10) pp. 5157-5162.

Ravirajan, CT; Pittoni, V; Isenberg, DA; (1999) Apoptosis in human autoimmune diseases. Int Rev Immunol , 18 (5-6) pp. 563-589.

Ravirajan, CT; Rahman, MA; Papadaki, L; Griffiths, MH; Kalsi, J; Martin, ACR; Ehrenstein, MR; ... Isenberg, DA; + view all (1999) Correction: Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis (European Journal of Immunology (1998) 28, 1 (339-350)). European Journal of Immunology , 29 (9) 3052-.

Ravirajan, CT; Rahman, MA; Papadaki, L; Griffiths, MH; Kalsi, J; Martin, ACR; Ehrenstein, MR; ... Isenberg, DA; + view all (1999) Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis (vol 28, pg 339, 1998). EUR J IMMUNOL , 29 (9) 3052 - 3052.

Read, J; Gill, R; Dales, SL; Cooper, JB; Wood, SP; Anthony, C; (1999) The molecular structure of an unusual cytochrome c(2) determined at 2.0 angstrom; the cytochrome c(H) from Methylobacterium extorquens. PROTEIN SCIENCE , 8 (6) pp. 1232-1240. 10.1110/ps.8.6.1232.

Ripley, BJM; Stephanou, A; Isenberg, DA; Latchman, DS; (1999) Interlenkin-10 activates heat-shock protein 90 beta gene expression. IMMUNOLOGY , 97 (2) 226 - 231.

Roberts, MM; Coker, AR; Fossati, C; Mascagni, P; Coates, ARM; Wood, SP; (1999) Crystallization, X-ray diffraction and preliminary structure analysis of Mycobacterium tuberculosis chaperonin 10. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY , 55 pp. 910-914. 10.1107/S0907444998018447.

Rubino, A; Loesch, A; Burnstock, G; (1999) Nitric oxide and endothelin-1 in coronary and pulmonary circulation. INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 189 , 189 pp. 59-93. 10.1016/S0074-7696(08)61385-6.

S

Saitongdee, P; Loesch, A; Knight, G; Milner, P; Burnstock, G; (1999) Ultrastructural localization of nitric oxide synthase and endothelin in the renal and mesenteric arteries of the golden hamster: Differences during and after arousal from hibernation. ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH , 6 (3) pp. 197-207. 10.3109/10623329909053410.

Saitongdee, P; Milner, P; Loesch, A; Knight, G; Burnstock, G; (1999) Electron-immunocytochemical studies of perivascular nerves of mesenteric and renal arteries of golden hamsters during and after arousal from hibernation. JOURNAL OF ANATOMY , 195 pp. 121-130. 10.1046/j.1469-7580.1999.19510121.x.

Situnayake, RD; Rahman, A; Bowman, S; Isenberg, DA; Gordon, C; (1999) Systemic lupus erythematosus into the next millennium: looking into the crystal ball. Lupus , 8 (9) pp. 716-722. 10.1191/096120399678840936.

Stangou, AJ; Booth, DR; Heaton, ND; Rela, M; Monaghan, M; Nihoyannopoulos, P; O'Grady, J; ... Hawkins, PN; + view all (1999) Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 330-332). PARTHENON PUBLISHING GROUP LTD

Stangou, AJ; Hawkins, PN; Booth, DR; O'Grady, J; Jewitt, D; Rela, M; Pepys, MB; (1999) Liver transplantation for non-Met30 TTR associated familial amyloid polyneuropathy: The UK experience. In: (pp. 304A-304A). W B SAUNDERS CO

Stangou, AJ; Heaton, ND; Rela, M; Jewitt, D; Mathias, CJ; O'Grady, J; Williams, RS; ... Hawkins, PN; + view all (1999) Orthotopic liver transplantation for familial amyloid polyneuropathy: the UK experience. In: Kyle, RA and Gertz, MA, (eds.) (Proceedings) VIIIth International Symposium on Amyloidosis. (pp. pp. 238-240). PARTHENON PUBLISHING GROUP LTD

Stephanou, A; Isenberg, DA; Nakajima, K; Latchman, DS; (1999) Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90 beta gene promoters. J BIOL CHEM , 274 (3) 1723 - 1728. Gold open access

Sultan, SM; Ioannou, Y; Isenberg, DA; (1999) A review of gastrointestinal manifestations of systemic lupus erythematosus. RHEUMATOLOGY , 38 (10) 917 - 932.

T

Tan, SY; Baillod, R; Brown, E; Farrington, K; Soper, C; Percy, M; Clutterbuck, E; ... Hawkins, PN; + view all (1999) Clinical, radiological and serum amyloid P component scintigraphic features of beta(2)-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION , 14 (6) pp. 1467-1471. 10.1093/ndt/14.6.1467.

Tennent, GA; (1999) Isolation and characterization of amyloid fibrils from tissue. In: UNSPECIFIED (26 - 47). ACADEMIC PRESS INC

Tennent, GA; Cafferty, KD; Pepys, MB; Hawkins, PN; (1999) Congo red overlay immunohistochemistry aids classification of amyloid deposits. In: Kyle, RA and Gertz, MA, (eds.) UNSPECIFIED (160 - 162). PARTHENON PUBLISHING GROUP LTD

Thompson, D; Pepys, MB; Wood, SP; (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. STRUCTURE , 7 (2) pp. 169-177. 10.1016/S0969-2126(99)80023-9.

Tunca, M; Kirkali, G; Soyturk, M; Akar, S; Pepys, MB; Hawkins, PN; (1999) Acute phase response and evolution of familial Mediterranean fever. LANCET , 353 (9162) p. 1415. 10.1016/S0140-6736(99)00990-3.

W

Walton, LJ; Franklin, IJ; Bayston, T; Brown, LC; Greenhalgh, RM; Taylor, GW; Powell, JT; (1999) Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation , 100 (1) pp. 48-54.

Wan, H; Winton, HL; Soeller, C; Tovey, ER; Gruenert, DC; Thompson, PJ; Stewart, GA; ... Robinson, C; + view all (1999) Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. JOURNAL OF CLINICAL INVESTIGATION , 104 (1) pp. 123-133. 10.1172/JCI5844.

Woo, P; Martin, K; (1999) Juvenile idiopathic arthritis. In: Isenberg, D and Miller, JJ, (eds.) Adolescent Rheumatology. (pp. 71-94). Martin Dunitz: London.

This list was generated on Sun Sep 8 06:57:58 2019 BST.